Metropolitan Life Insurance Company (MetLife)’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-20,238
| Closed | -$408K | – | 2867 |
|
|
2021
Q3 | $408K | Hold |
20,238
| – | – | 0.01% | 1585 |
|
|
2021
Q2 | $755K | Buy |
20,238
+829
| +4% | +$30.9K | 0.01% | 1226 |
|
|
2021
Q1 | $496K | Sell |
19,409
-641
| -3% | -$16.4K | 0.01% | 1413 |
|
|
2020
Q4 | $442K | Hold |
20,050
| – | – | 0.01% | 1436 |
|
|
2020
Q3 | $361K | Hold |
20,050
| – | – | 0.01% | 1430 |
|
|
2020
Q2 | $509K | Buy |
20,050
+1,940
| +11% | +$49.3K | 0.01% | 1181 |
|
|
2020
Q1 | $333K | Hold |
18,110
| – | – | 0.01% | 1295 |
|
|
2019
Q4 | $399K | Hold |
18,110
| – | – | 0.01% | 1467 |
|
|
2019
Q3 | $260K | Hold |
18,110
| – | – | ﹤0.01% | 1695 |
|
|
2019
Q2 | $285K | Buy |
18,110
+879
| +5% | +$13.8K | ﹤0.01% | 1655 |
|
|
2019
Q1 | $252K | Sell |
17,231
-1,238
| -7% | -$18.1K | ﹤0.01% | 1747 |
|
|
2018
Q4 | $197K | Buy |
18,469
+3,136
| +20% | +$33.5K | ﹤0.01% | 1828 |
|
|
2018
Q3 | $234K | Hold |
15,333
| – | – | ﹤0.01% | 1896 |
|
|
2018
Q2 | $188K | Buy |
+15,333
| New | +$188K | ﹤0.01% | 1983 |
|
|
2016
Q1 | – | Sell |
-11,866
| Closed | -$141K | – | 2541 |
|
|
2015
Q4 | $141K | Buy |
+11,866
| New | +$141K | ﹤0.01% | 2459 |
|